Screener
Alaunos Therapeutics TCRT Q1 2025 Annual earnings
Reported May 15, 2025 · Before market open
Revenue$2.0K
EPS-$0.67Beat by $5.77
EPS estimate-$6.44
Next report
Nov 17, 2026 (in 2 months)EPS estimate-$15.75
Versus estimates
Revenue
Q4 2025$3.0KIn line
Q1 2025$2.0K
Diluted EPS
Q2 2026-$0.41Q1 2026-$0.59Q4 2025-$0.40Beat by $3.29Q3 2025-$0.55Beat by $4.35Q2 2025-$0.63Beat by $4.70
Q1 2025-$0.67Beat by $5.77
FAQ
- When did Alaunos Therapeutics report Q1 2025 earnings?
- Alaunos Therapeutics (TCRT) reported Q1 2025 earnings on May 15, 2025 before market open.
- What were Alaunos Therapeutics's Q1 2025 revenue and EPS?
- Alaunos Therapeutics reported revenue of $2.0K and eps of $-0.67 for Q1 2025.
- Did Alaunos Therapeutics beat estimates in Q1 2025?
- EPS beat the consensus estimate of $-6.44 by $5.77.
- How did Alaunos Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 100.0% from $1.0K a year earlier and eps grew 39.1% from $-1.10.
- Where can I find Alaunos Therapeutics's Q1 2025 SEC filings?
- You can read the 10-K periodic report (0000950170-25-047758) directly on SEC EDGAR. The filing index links above go to sec.gov.
